Sage Journals: Discover world-class research

Abstract

Keywords

Botulinum toxin

Get full access to this article

View all access options for this article.

References

Wiegand

Erdmann

Wellhoner

. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976; 292 (2): 161–5.

Tang-Liu

Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon 2003; 42 (5): 461–9.

Naumann

Jankovic

. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin 2004; 20 (7): 981–90.

Apostolidis

Dasgupta

Denys

Elneil

Fowler

Giannantoni

Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 2008 [Epub ahead of print].

“Paraplegia as a Complication of Intravesical Botulinum Toxin A (Dysport®) Injection for Overactive Bladder” by Awsare and Jones [Br. J. Med. Surg. Urol. 2 (2009) 127–128]

Abstract

Keywords

Get full access to this article

References